These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 6754634

  • 1. The hypotensive effect of a single daily dose of labetalol: a preliminary study.
    Rossi A, Ziacchi V, Lomanto B.
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):438-45. PubMed ID: 6754634
    [Abstract] [Full Text] [Related]

  • 2. Experience with labetalol in hypertension.
    Bolli P, Waal-Manning J, Wood AJ, Simpson FO.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):765-71. PubMed ID: 791330
    [Abstract] [Full Text] [Related]

  • 3. Labetalol in resistant hypertension.
    Dargie HJ, Dollery CT, Daniel J.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):751-5. PubMed ID: 990154
    [Abstract] [Full Text] [Related]

  • 4. Double-blind trial of labetalol.
    Kane J, Gregg I, Richards DA.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329
    [Abstract] [Full Text] [Related]

  • 5. Controlled comparison of labetalol and propranolol in the management of severe hypertension.
    Pugsley DJ, Armstrong BK, Nassim MA, Beilin LJ.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):777-82. PubMed ID: 791331
    [Abstract] [Full Text] [Related]

  • 6. Acute management of severe hypertension with oral labetalol.
    Ghose RR.
    Br J Clin Pharmacol; 1979 Aug; 8(Suppl 2):189S-193S. PubMed ID: 526400
    [Abstract] [Full Text] [Related]

  • 7. Labetalol and pindolol in the treatment of hypertension: a comparative study.
    Romo M, Halttunen P, Saarinen P, Sarna S.
    Ann Clin Res; 1979 Dec; 11(6):249-52. PubMed ID: 398184
    [Abstract] [Full Text] [Related]

  • 8. A multicentre study of labetalol in hypertension. New Zealand Hypertension Study Group.
    N Z Med J; 1981 Apr 08; 93(681):215-8. PubMed ID: 7017511
    [Abstract] [Full Text] [Related]

  • 9. A controlled comparison of the antihypertensive effects of labetalol and alpha-methyldopa.
    Al-Damluji SF, Al-Khalidi A, Shaarbaf H, Tawfiq NH.
    Pharmatherapeutica; 1982 Apr 08; 3(2):133-9. PubMed ID: 7048338
    [Abstract] [Full Text] [Related]

  • 10. A double-blind crossover clinical trial of labetalol and propranolol in patients of essential hypertension.
    Pandhi P, Aslam S, Sharma BK, Sharma PL, Wahi PL.
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb 08; 23(2):101-4. PubMed ID: 3886563
    [Abstract] [Full Text] [Related]

  • 11. A comparative study of methyldopa and labetalol in the treatment of hypertension.
    Sanders GL, Davies DM, Gales GM, Rao JG, Rawlins MD, Routledge PA.
    Br J Clin Pharmacol; 1979 Feb 08; 8(Suppl 2):149S-151S. PubMed ID: 393286
    [Abstract] [Full Text] [Related]

  • 12. The effect of exercise on intra-arterial blood pressure and pulse rate before and during long-term high-dose treatment with labetalol in patients with severe, therapy-resistant hypertension.
    la Cour Petersen E, Kristensen BO.
    Postgrad Med J; 1980 Feb 08; 56 Suppl 2():60-4. PubMed ID: 7433345
    [Abstract] [Full Text] [Related]

  • 13. Long-term treatment of hypertension with labetalol.
    Erichs M, Rothgardt NP, Andersson E.
    Postgrad Med J; 1980 Feb 08; 56 Suppl 2():53-6. PubMed ID: 7433343
    [Abstract] [Full Text] [Related]

  • 14. Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.
    Thompson FD, Joekes AM, Hussein MM.
    Br J Clin Pharmacol; 1979 Feb 08; 8(Suppl 2):129S-133S. PubMed ID: 526392
    [Abstract] [Full Text] [Related]

  • 15. [Labetalol in the treatment of arterial hypertension. A Brazilian multicenter study].
    Benchimol AB, Sbissa AS, Benchimol CB, Saad EA, Barbosa ET, Albanesi Filho FM, Pillegi F, da Cunha GP, Maranhão MF, Batlouni M, Schlesinger P, Duprat R, Maciel R.
    Arq Bras Cardiol; 1982 May 08; 38(5):421-7. PubMed ID: 6762868
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of severe essential hypertension with labetalol: effect on active and inactive renin.
    Hauger-Klevene JH.
    Pharmatherapeutica; 1981 May 08; 3(1):46-54. PubMed ID: 7033992
    [Abstract] [Full Text] [Related]

  • 17. A comparison and an investigation of a potential synergistic effect of labetalol and bethanidine in patients with mild hypertension.
    Chalmers AG, Hunter J, Lees CD, Millar JA, Brown JJ, Robertson JI.
    Br J Clin Pharmacol; 1979 May 08; 8(Suppl 2):183S-187S. PubMed ID: 526399
    [Abstract] [Full Text] [Related]

  • 18. Treatment of hypertension with labetalol.
    Bolli P, Waal-Manning HJ, Simpson FO, Seeman HM.
    N Z Med J; 1977 Dec 28; 86(602):557-63. PubMed ID: 306082
    [Abstract] [Full Text] [Related]

  • 19. Labetalol in severe and resistant hypertension.
    Williams LC, Murphy MJ, Parsons V.
    Br J Clin Pharmacol; 1979 Dec 28; 8(Suppl 2):143S-147S. PubMed ID: 526395
    [Abstract] [Full Text] [Related]

  • 20. A multicentre open trial of labetalol in New Zealand.
    Br J Clin Pharmacol; 1979 Dec 28; 8(Suppl 2):179S-182S. PubMed ID: 393287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.